Forteo
Drug
Lilly USA, LLC
Total Payments
$334,495
Transactions
7
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $262,055 | 2 | 0 |
| 2017 | $72,440 | 5 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $334,495 | 7 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| FORTEO IN SPINAL FUSION | Lilly USA, LLC | $204,504 | 0 |
| THE ROLE OF TERIPARATIDE FOR HEALING OF ATYPICAL FEMORAL SHAFT | Lilly USA, LLC | $57,551 | 0 |
| THE USE OF TERIPARATIDE AS AN ADJUNCTIVE THERAPY FOR THE TREATMENT OF JONES FRACTURES | Lilly USA, LLC | $53,567 | 0 |
| TERIPARATIDE AND RISEDRONATE IN THE TREATMENT OF PATIENTS WITH SEVERE POSTMENOPAUSAL OSTEOPOROSIS - COMPARATIVE EFFECTS ON VERTEBRAL FRACTURES | Lilly USA, LLC | $18,873 | 0 |
Top Doctors Receiving Payments for Forteo
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Upper Arlington, OH | $334,495 | 7 |
Ad
Manufacturing Companies
- Lilly USA, LLC $334,495
Product Information
- Type Drug
- Total Payments $334,495
- Total Doctors 0
- Transactions 7
About Forteo
Forteo is a drug associated with $334,495 in payments to 0 healthcare providers, recorded across 7 transactions in the CMS Open Payments database. The primary manufacturer is Lilly USA, LLC.
Payment data is available from 2017 to 2018. In 2018, $262,055 was paid across 2 transactions to 0 doctors.
The most common payment nature for Forteo is "Unspecified" ($334,495, 100.0% of total).
Forteo is associated with 4 research studies, including "FORTEO IN SPINAL FUSION" ($204,504).